Zobrazeno 1 - 10
of 121
pro vyhledávání: '"O. E. Iversen"'
Autor:
E. D. Moreira, A. R. Giuliano, J. de Hoon, O.-E. Iversen, E. A. Joura, J. Restrepo, P. Van Damme, C. Vandermeulen, M. C. Ellison, A. Krick, C. Shields, B. Heiles, A. Luxembourg
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 2, Pp 396-403 (2018)
A 9-valent HPV (9vHPV) vaccine has been developed to protect against HPV type 6/11/16/18/31/33/45/52/58-related infection and disease. Previous safety analyses from 7 clinical trials conducted in 9vHPV vaccine recipients 9–26 years of age, includin
Externí odkaz:
https://doaj.org/article/d6ea694c0aa84549a09949cf3327ab63
Autor:
O-E Iversen, Kristjan Sigurdsson, Joakim Dillner, Mark T. Esser, Jorma Paavonen, Frank J. Taddeo, Janine T. Bryan, S-E Olsson, Scott Vuocolo, F. X. Bosch, Slawomir Majewski, Eliav Barr, Margaret James, Katherine E.D. Giacoletti, Susanne K. Kjaer, N. Munoz
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 23:1147-1155
Background Quadrivalent human papillomavirus (HPV types 6/11/16/18) L1 VLP vaccine is highly effective in preventing HPV 6/11/16/18-related cervical and external genital disease. Herein, we evaluated the impact of the quadrivalent HPV 6/11/16/18 L1 V
Autor:
J. Hoye, G. Von Krogh, Carlos Alberto Petta, Mark T. Esser, A. Andersson-Ellstrom, Kristina Elfgren, O-E Iversen, Luisa L. Villa, Gretchen M. Tamms, Eliav Barr, Katherine E.D. Giacoletti, Heather L. Sings, Rosires Pereira de Andrade, Alfred Saah, Jorma Paavonen, Matti Lehtinen, Radha Railkar, Christian Malm, G. Riis-Johannessen, Frank J. Taddeo, Lisa Lupinacci, Margareta Steinwall, Ronaldo L.R. Costa, S-E Olsson, Janine T. Bryan
Publikováno v:
British Journal of Cancer
Human papillomavirus (HPV) causes cervical, vulvar, and vaginal cancers, precancerous dysplasia, and genital warts. We report data for the longest efficacy evaluation to date of a prophylactic HPV vaccine. In total, 552 women (16-23 years) were enrol
Publikováno v:
Acta Anaesthesiologica Scandinavica. 50:358-363
Background: The use of regional anesthesia for elective Cesarean section has been demonstrated to be safe for both the mother and new-born. In parturients with an epidural catheter placed previously for labor analgesia, extension of the epidural bloc
Publikováno v:
European Journal of Anaesthesiology. 21:776-780
Autor:
N. D. Macdonald, H. B. Salvesen, A. Ryan, S. Malatos, I. Stefansson, O. E. Iversen, L. A. Akslen, S. Das, I. J. Jacobs
Publikováno v:
International Journal of Gynecologic Cancer. 14:957-965
Studies, to date, have suggested that there are distinct molecular differences between microsatellite stable (RER–) and unstable (RER+) solid tumors, such as colorectal carcinoma. We investigated a range of molecular events including mutation frequ
Autor:
L, Bjørge, S L, Johnsen, G, Midbøe, G, Augestad, I, Økland, H, Helland, S, Stray-Pedersen, O E, Iversen
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 80:1056-1061
Medical abortion was first introduced in Norway in April 1998. The aims of this study were to assess the efficacy, side effects, and acceptability of medical abortion using mifepristone orally and misoprostol vaginally in a Norwegian population.The s
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 78:33-36
To determine the incidence and complications related to manual removal of the placenta.Review of hospital medical records from 1990 throughout 1994. One thousand five hundred and two vaginal deliveries from 1984 1992 were used for comparisons.A total
Publikováno v:
European journal of anaesthesiology. 21(10)
In 1991 general anaesthesia was used extensively for emergency Caesarean section at Haukeland University Hospital even in patients with an ongoing epidural infusion. With increased knowledge of the potential safety benefits of regional anaesthesia an
Autor:
O E, Iversen
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 121(1)